CISL

Coalition June Newsletter

27th June 2017
Published under: Featured,Natural Capital Coalition

Our June newsletter goes live! Sign up to our newsletter at the bottom of this page. Read the newsletter here.

Natural Capital Protocol: Case Study for Roche

22nd June 2017
Published under: Case Studies,Featured

The company in brief: F. Hoffmann-La Roche AG (Roche) is a Swiss multinational healthcare company headquartered in Basel, operating in the fields of pharmaceuticals and diagnostics. As part of their existing sustainability program, Roche identifies environmental risks at a local and global level using an approach called EcoBalance, an internal procedure to measure and manage… [more]

Natural Capital Protocol: Case Study for Yorkshire Water

22nd June 2017
Published under: Case Studies,Featured

The company in brief: Yorkshire Water is a water and waste water services utility company servicing 5m domestic customers and 136,000 business premises in West Yorkshire, South Yorkshire, the East Riding of Yorkshire, part of North Lincolnshire, most of North Yorkshire and part of Derbyshire, in England. Why a natural capital assessment? Yorkshire Water, assisted… [more]

Natural Capital Protocol: Case Study for Skanska

22nd June 2017
Published under: Case Studies,Featured

The company in brief: Skanska is one of the world’s leading project development and construction groups. The company helps finance, design, construct and maintain buildings including schools, offices and hospitals and infrastructure such as roads and rail. Within its 2020 ’Accounting for Sustainability’ strategy, Skanska UK set the ambitious target of embedding the natural capital… [more]

Natural Capital Protocol: Case Study for Novartis

22nd June 2017
Published under: Case Studies,Featured

The company in brief: Novartis is a multinational pharmaceutical company based in Switzerland, and one of the largest pharmaceutical companies by both market cap and sales. Novartis develops, manufactures, and markets healthcare products, providing solutions for patients worldwide. The company operates in the segments of innovative pharmaceuticals, eyecare, generics, vaccines/diagnostics and consumer health. Why a… [more]

Natural Capital Protocol: Case Study for AkzoNobel

22nd June 2017
Published under: Case Studies,Featured

The company in brief: AkzoNobel is a Dutch multinational chemical company, producing paints, performance coatings and speciality chemicals, and supplying paint ingredients, protection and colours to a worldwide industry and consumer base. The company’s products are also inputs to a variety of industrial manufacturing streams for pharmaceuticals, pulp and paper, and in the production of… [more]